Related Experiment Videos
Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1
Prostaglandins and Medicine
|August 1, 1981
Abstract:
In two of three patients with peripheral vascular disease, systemic infusion of PGE1 inhibited chemotactic factor induced secretion of glucosaminidase from neutrophils.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Development and evaluation of an instrument to assess medical students' cultural attitudes.
Journal of the American Medical Women's Association (1972)·2007
The difficulty of sustaining curricular reforms: a study of "drift" at one school.
Academic medicine : journal of the Association of American Medical Colleges·2000
In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12.
Infection and immunity·1998
L-selectin stimulation of canine neutrophil initiates calcium signal secondary to tyrosine kinase activation.
The American journal of physiology·1997
A predictive model of student satisfaction with the medical school learning environment.
Academic medicine : journal of the Association of American Medical Colleges·1997
Effects of arachidonic acid hydroperoxides on vascular and non-vascular smooth muscle.
Prostaglandins and medicine·1981
An intrauterine silastic system for the sustained release of indomethacin.
Prostaglandins and medicine·1981
Prostacyclin effect on cardiovascular system in man evaluated by echocardiography.
Prostaglandins and medicine·1981
Response of the soft tissue microcirculation to prostacyclin infusion.
Prostaglandins and medicine·1981
Dissociation of vascular resistance with endocrine pancreas secretion: the effects of epoxymethano analogs of PGH2.
Prostaglandins and medicine·1981
Topical treatment of rosacea: update and outlook.
International journal of pharmaceutics·2026
Structural and molecular insights into the binding mechanisms of β-glucosidase-ascorbic acid-rutin/isoquercetin ternary systems.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026